Product description
Ircal and Refresh Night Time Eye Ointments
See a list of details to help identify the product
Reason the product is recalled
Small particles of black plastic may be ground off the lids of some ointment tubes when opening, with the potential for these particles to be introduced into the ointment.
The hazards to consumers
If these particles were to be introduced into the eye there is the potential for discomfort, irritation, pain, swelling or abrasion.
What consumers should do
Consumers should return the product to the place of purchase for a refund or replacement.
Details to help identify the product
Supplier running the recall
Allergan Australia Pty Ltd
Identifying product features
Ircal 2 x 3.5 g ointment 86908 (expiry date 12/17)
Refresh Night Time 1 x 3.5 g ointment 85422 (expiry date 06/17)
86516 (expiry date 09/17)
87052 (expiry date 11/17)
87437 (expiry date 02/18)
Refresh Night Time 2 x 3.5 g ointment 84683 (expiry date 04/17)
85422 (expiry date 06/17)
85432 (expiry date 06/17)
86514 (expiry date 09/17)
86934 (expiry date 12/17).
Identifying numbers
Other identifying numbers
Ircal 2 x 3.5 g ointment 86908 (expiry date 12/17)
Refresh Night Time 1 x 3.5 g ointment 85422 (expiry date 06/17)
86516 (expiry date 09/17)
87052 (expiry date 11/17)
87437 (expiry date 02/18)
Refresh Night Time 2 x 3.5 g ointment 84683 (expiry date 04/17)
85422 (expiry date 06/17)
85432 (expiry date 06/17)
86514 (expiry date 09/17)
86934 (expiry date 12/17).
Refresh Night Time 1 x 3.5 g ointment 85422 (expiry date 06/17)
86516 (expiry date 09/17)
87052 (expiry date 11/17)
87437 (expiry date 02/18)
Refresh Night Time 2 x 3.5 g ointment 84683 (expiry date 04/17)
85422 (expiry date 06/17)
85432 (expiry date 06/17)
86514 (expiry date 09/17)
86934 (expiry date 12/17).
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2015/14934 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.